Exxon? Apple? Berkshire Hathaway? No, it's another stock I would own if I could only own one. For 60 years it has produced an average annual return of roughly 20%.
By Marshall Hargrave | Aug 10, 2016
Earnings season came and went with a bang. Here are two of the most attractive stocks in this season's two strongest sectors.
By Bob Ciura | Jun 27, 2016
These robust health-care dividend stocks will continue growing as baby boomers increase in number and need greater services.
By Bob Ciura | May 5, 2016
Exxon Mobil's credit downgrade by Standard & Poor's leaves just two triple-A rated companies in the United States.
By Bob Ciura | Jan 8, 2016
After a whipsaw year for Big Pharma stocks in 2015, there are some compelling value opportunities out there.
By Lawrence Meyers | Dec 2, 2015
Do the current Dow 30 stocks really represent the economy as broadly as possible?
By Bob Ciura | Oct 13, 2015
Despite missing revenue projections by $340 million, Johnson & Johnson remains a quality blue chip stock that dividend investors can count on.
By Bob Ciura | Sep 3, 2015
After the recent market plunge, long-term investors should consider these three Dow dividend stocks to buy now on the cheap.
By Marshall Hargrave | Jun 5, 2015
Last week we found out that gross domestic product contracted at an annual rate of 0.7%. That’s well below the 0.2% fall that economists were expecting.
By Jim Nelson | May 8, 2015
Pay attention to these, the most attractive among dividend stocks on the Dow. Now is the time to jump in.